文献速递妇产影像US

妊娠11-13周颈项透明层增厚与双胎妊娠结局

Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-02-13

该回顾性分析纳入2002至2019年间6225例双胎妊娠,评估11-13周颈项透明层≥95百分位对不良结局的预测价值。在无重大畸形的单绒毛膜双羊膜囊双胎中,颈项透明层≥95百分位预测20周前胎儿丢失或需内镜激光手术的检出率仅23.5%,假阳性率8.9%,相对风险2.640(95%CI 1.854-3.758;P<0.0001),筛查效能差,但风险显著增加。

要点

  • 单绒毛膜双羊膜囊双胎中,颈项透明层≥95百分位者20周前胎儿丢失或需激光手术风险显著升高(23.5% vs 9.8%;P<0.0001)。
  • 颈项透明层≥95百分位预测20周前胎儿丢失或需激光手术的检出率23.5%、假阳性率8.9%,筛查效能差。
  • 单绒毛膜双羊膜囊双胎中,颈项透明层≥99百分位者20周前胎儿丢失或需激光手术率达40.5%,风险进一步增加。

核心结论

  • 在无重大胎儿畸形的单绒毛膜双羊膜囊双胎中,11-13周颈项透明层测量对不良妊娠结局的筛查效能差,但颈项透明层≥95百分位(尤其≥99百分位)与20周前胎儿丢失或需内镜激光手术风险显著增加相关。

研究设计与样本

  • 回顾性分析前瞻性收集的2002至2019年间在11-13周接受常规超声检查的双胎妊娠数据,共6225例,包括双绒毛膜双胎4896例(78.7%)、单绒毛膜双羊膜囊双胎1274例(20.5%)和单绒毛膜单羊膜囊双胎55例(0.9%)。

诊断标准与关键数值

  • 双绒毛膜双胎中,一个或两个胎儿颈项透明层≥95百分位的发生率为8.3%。
  • 单绒毛膜双羊膜囊双胎中颈项透明层≥95百分位的发生率为10.4%,显著高于双绒毛膜双胎(P=0.016)。
  • 单绒毛膜单羊膜囊双胎中颈项透明层≥95百分位的发生率为9.1%,与双绒毛膜双胎无显著差异(P=0.804)。
  • 单绒毛膜双羊膜囊双胎中,至少一个胎儿死亡或20周前需内镜激光手术者颈项透明层≥95百分位的发生率为23.5%,显著高于双活产者的9.8%(P<0.0001)。
  • 单绒毛膜双羊膜囊双胎中,颈项透明层≥95百分位预测20周前胎儿丢失或需内镜激光手术的检出率为23.5%,假阳性率为8.9%,相对风险为2.640(95%CI 1.854-3.758;P<0.0001)。

临床应用与阅片要点

  • 在单绒毛膜双羊膜囊双胎妊娠中,11-13周颈项透明层≥95百分位(尤其≥99百分位)提示20周前胎儿丢失或需内镜激光手术风险增加,但作为筛查试验效能差;作者认为更密切监测和早期干预能否减少这些并发症尚待确定。

局限性

  • 单绒毛膜单羊膜囊双胎病例数过少,无法有意义地评估颈项透明层增高与不良结局的关系。
  • 更密切监测和早期干预能否减少高危组的这些并发症尚待确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of increased fetal nuchal translucency thickness (NT) at the 11-13-week scan in the prediction of adverse outcome in dichorionic (DC), monochorionic diamniotic (MCDA) and monochorionic monoamniotic (MCMA) twin pregnancies.

METHODS: This was a retrospective analysis of prospectively collected data on twin pregnancies undergoing routine ultrasound examination at 11-13 weeks' gestation between 2002 and 2019. In pregnancies with no major defects or chromosomal abnormalities, we examined the value of increased NT ≥ 95th percentile in one or both fetuses in the prediction of, first, miscarriage or death of one or both fetuses at < 20 and < 24 weeks' gestation in DC, MCDA and MCMA twin pregnancies, second, death of one or both fetuses or neonates at ≥ 24 weeks in DC, MCDA and MCMA twin pregnancies, third, development of twin-twin transfusion syndrome (TTTS) or selective fetal growth restriction (sFGR) treated by endoscopic laser surgery at < 20 and ≥ 20 weeks' gestation in MCDA pregnancies, and, fourth, either fetal loss or laser surgery at < 20 weeks' gestation in MCDA pregnancies.

RESULTS: The study population of 6225 twin pregnancies included 4896 (78.7%) DC, 1274 (20.5%) MCDA and 55 (0.9%) MCMA pregnancies. The incidence of NT ≥ 95th percentile in one or both fetuses in DC twin pregnancies was 8.3%; in MCDA twins the incidence was significantly higher (10.4%; P = 0.016), but in MCMA twins it was not significantly different (9.1%; P = 0.804) from that in DC twins. In DC twin pregnancies, the incidence of high NT was not significantly different between those with two survivors and those with adverse outcome. In MCMA twin pregnancies, the number of cases was too small for meaningful assessment of the relationship between high NT and adverse outcome. In MCDA twin pregnancies with at least one fetal death or need for endoscopic laser surgery at < 20 weeks' gestation, the incidence of NT ≥ 95th percentile was significantly higher than in those with two survivors (23.5% vs 9.8%; P < 0.0001). Kaplan-Meier analysis in MCDA twin pregnancies showed that, in those with NT ≥ 95th percentile, there was significantly lower survival at < 20 weeks' gestation than in those with NT < 95th percentile (P = 0.001); this was not the case for survival at ≥ 20 weeks (P = 0.960). The performance of screening by fetal NT ≥ 95th percentile for prediction of either fetal loss or need for endoscopic laser surgery at < 20 weeks' gestation was poor, with a detection rate of 23.5% at a false-positive rate of 8.9%, and the relative risk, in comparison to fetal NT < 95th percentile, was 2.640 (95% CI, 1.854-3.758; P < 0.0001). In MCDA twin pregnancies, the overall rate of fetal loss or need for laser surgery at < 20 weeks' gestation was 10.7% but, in the subgroups with NT ≥ 95th and NT ≥ 99th percentiles, which constituted 10.4% and 3.3% of the total, the rates increased to 24.1% and 40.5%, respectively.

CONCLUSIONS: In MCDA twin pregnancies with no major fetal abnormalities, measurement of NT at the 11-13-week scan is a poor screening test for adverse pregnancy outcome. However, the finding in one or both fetuses of NT ≥ 95th percentile, and more so ≥ 99th percentile, is associated with a substantially increased risk of fetal loss or need for endoscopic laser surgery at < 20 weeks' gestation. The extent to which closer monitoring and earlier intervention in the high-risk group can reduce these complications remains to be determined. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cimpoca B, Syngelaki A, Litwinska E, et al. Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy. Ultrasound Obstet Gynecol. 2020. PMID: 31773823. doi:10.1002/uog.21935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。